Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.

Explore this paper's citation graph

Summary

Self-expanding TAVR compares favorably with SAVR in high-risk patients with STS PROM scores traditionally considered intermediate risk, and the contribution to survival based on the degree of invasiveness of the T AVR procedure will decrease, making it more difficult to show improved survival and benefit over SAVr.

Type
article
Published
2016-11-01
Cited by
74
References
15
Access
Open access

Keywords

Medicine, Prom, Randomized controlled trial, Internal medicine, Valve replacement

References

Cited by

Related papers